At the Kidney Cancer Research Summit (KCRS26) in Boston, Dr. Toni Choueiri, Medical Doctor and Professor at Dana-Farber Cancer Institute, was honored with the inaugural KidneyCAN Hall of Fame Lifetime Achievement Award, celebrating his pivotal contributions to renal cell carcinoma research. Leading oncologists praised his role in steering practice-changing clinical trials, alongside his dedicated mentorship that has shaped generations of kidney cancer investigators worldwide.
Tom Powles։
“Toni Choueiri receiving the lifetime achievement award. Leading a plethora of practice-changing trials from METEOR to LITESPARK. >900 publications. Amazing achievement and well deserved.”

Shilpa Gupta։
“So richly deserved! Congratulations to the incomparable Toni Choueiri, an extraordinary leader, mentor, and a true giant in kidney cancer!”
Tian Zhang։
“Toni Choueiri receives the first KidneyCAN Hall of Fame award – testament to his decades of mentorship and impact to the field. Standing ovation in Boston. Congrats Toni – well deserved!”
Yüksel Ürün։
“The true legacy of mentorship is not one successful investigator, but generations of them. Toni Choueiri’s impact on the global RCC community is extraordinary.”
Katy Beckermann։
“A KCRS26 Hall of Fame honor that could not be more deserved. Decades of mentorship, generosity, and relentless advancement of the entire kidney cancer field. So many of us are here because Toni Choueiri lit the path and then held the door open. Congratulations, and thank you.”
Other articles about KidneyCAN on OncoDaily.


